https://www.selleckchem.com/pr....oducts/Staurosporine
5% (108/143) vs. 35.7% (337/944), P less then 0.0001, prevalence ratio, 2.1] and fetal vascular malperfusion lesions [88.1% (126/143) vs. 19.7% (186/944), P less then 0.0001, prevalence ratio, 4.5]; (3) higher frequency of placental histologic patterns suggestive of hypoxia [59.0% (85/143) vs. 9.3% (82/942), P less then 0.0001, prevalence ratio, 6.8]; and (4) higher frequency of chronic inflammatory lesions [53.1% (76/143) vs. 29.9% (282/944), P less then 0.001, prevalence ratio 1.8]. Conclusion This study demonstrates tha
Like
Comment
Share
